Biosciences

Filter Op Archive
Clear all
Blijf op de hoogte van ons nieuws
  • Covid vaccine patent waivers – the opinion of our vaccine IP specialist

    May 6, 2021 | Tags: Octrooien , Biosciences , IP Insight

  • Medical inventions – a European perspective

    Jan 19, 2021 | Tags: Octrooien , Biosciences , IP Insight

  • No SPCs for new therapeutic applications of old drugs – CJEU overturns Neurim

    Jul 16, 2020 | Tags: Octrooien , Biosciences , IP Insight

  • “No Patents On Peppers”… or any plants or animals exclusively obtained by means of an essentially biological process

    May 27, 2020 | Tags: Octrooien , Biosciences , Food and drink , IP Insight

  • Mobile apps at the forefront of the Covid-19 fight

    May 13, 2020 | Tags: Octrooien , Merken , Biosciences , Modellen , Software

  • Institutions inject flexibility into IP relevant to COVID-19 vaccines and medicines

    Apr 22, 2020 | Tags: Octrooien , Biosciences

  • News Flash Update: EPO and EUIPO Deadlines extended

    Mar 16, 2020 | Tags: Octrooien , Merken , Biosciences , Modellen

  • Vitamins, Nutraceuticals and Trade Marks

    Aug 12, 2019 | Tags: Merken , Biosciences , Food and drink

  • UK Supreme Court approves ‘Skinny Labelling’ (pdf)

    Dec 18, 2018 | Tags: Octrooien , Biosciences , IP Insight

  • The UK Supreme Court re-vitalises patent infringement by equivalents (pdf)

    Jul 13, 2017 | Tags: Octrooien , Biosciences

  • Is it obvious to try? December 2015 (pdf)

    Dec 3, 2015 | Tags: Octrooien , Biosciences

  • Second Medical Use Claims - a painful odyssey (pdf)

    May 6, 2015 | Tags: Octrooien , Biosciences

  • Biosciences and Pharma Group Newsletter - May 2013 (pdf)

    May 1, 2013 | Tags: Octrooien , Biosciences